Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis

Beta-adrenergic signaling, a novel target for cancer therapy?

(2015)   Oncotarget

Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

(2015)   Oncotarget

Oncogenic KRAS Desensitizes Colorectal Tumor Cells to Epidermal Growth Factor Receptor Inhibition and Activation

(2015) Winan J. van Houdt et al.   NEOPLASIA

Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells

(2014) Pintusorn Hansakul et al.   BMC Complementary and Alternative Medicine

Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells

(2014) Yanrong Qian et al.   CANCER LETTERS

β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling

(2014) Massimo Dal Monte et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

beta-Adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration

(2014) Özlem Darcansoy İşeri et al.   PHARMACEUTICAL BIOLOGY

Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization

(2013) Massimo Dal Monte et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines

(2013) Silvia Moretti et al.   LABORATORY INVESTIGATION

Colorectal cancer

(2013) Hermann Brenner et al.   LANCET

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

(2013) Cosimo Commisso et al.   NATURE

Effect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice

(2013) Qiang Lin et al.   PLoS One

Epigenetics and Colorectal Cancer Pathogenesis

(2013) Kankana Bardhan et al.   Cancers

The Beta2-Adrenergic Receptor is a Potential Prognostic Biomarker for Human Hepatocellular Carcinoma After Curative Resection

(2012) Dongtai Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Molecular Genetics of Colorectal Cancer

(2011) Eric R. Fearon   Annual Review of Pathology-Mechanisms of Disease

β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines

(2011) Kelley S. Madden et al.   BREAST CANCER RESEARCH AND TREATMENT

Beta Blockers and Breast Cancer Mortality: A Population- Based Study

(2011) Thomas I. Barron et al.   JOURNAL OF CLINICAL ONCOLOGY

Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer

(2011) Amal Melhem-Bertrandt et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of adrenaline in human colon adenocarcinoma HT-29 cells

(2011) Helen P.S. Wong et al.   LIFE SCIENCES

β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway

(2011) Dong Zhang et al.   Molecular Cancer

Prevention of pancreatic cancer by the beta-blocker propranolol

(2010) Hussein A. Al-Wadei et al.   ANTI-CANCER DRUGS

The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells

(2010) Ming Shi et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF-κB and AP-1

(2010) Dong Zhang et al.   CANCER BIOLOGY & THERAPY

The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer

(2010) E. K. Sloan et al.   CANCER RESEARCH

Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer

(2010) M. Janakiraman et al.   CANCER RESEARCH

Colorectal Cancer: National and International Perspective on the Burden of Disease and Public Health Impact

(2010) Ziad F. Gellad et al.   GASTROENTEROLOGY

Expression of β2-adrenergic receptor in oral squamous cell carcinoma

(2010) Zheng Jun Shang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy

(2009) Ahmad D. Siddiqui et al.   ANNALS OF SURGICAL ONCOLOGY

Upregulation of β3-Adrenergic Receptor mRNA in Human Colon Cancer: A Preliminary Study

(2008) Maria Grazia Perrone et al.   ONCOLOGY

Hormonal regulation of β2-adrenergic receptor level in prostate cancer

(2008) Håkon Ramberg et al.   PROSTATE

Aberrant Prothymosin-alpha Expression in Human Bladder Cancer

(2008) Yuh-Shyan Tsai et al.   UROLOGY